Part,  Chapter, Paragraph

 1    I,     2. 10.  4|       resulted in a reduction of 74% in administration errors (
 2   II,     4.  2    |           For men, age groups 65-74 contributed almost one fourth
 3   II,     4.  2    |       mortality of women aged 65-74 has declined considerably.
 4   II,     5.  2.  2|          age-standardized for 35-74 years using the EUROSTAT
 5   II,     5.  2.  2|       standard. The age range 35-74 years is recommended because
 6   II,     5.  2.  2|        events are rare and above 74 years age structure differs
 7   II,     5.  2.  2| calculated.~Age-standardized (35-74 years) mortality rates were
 8   II,     5.  2.  2|      states age-standardized (35-74 years) mortality rate are
 9   II,     5.  2.  2|      rates for the age groups 35-74 and 35-84 years separately
10   II,     5.  2.  3|      mortality rates only for 35-74 age range, as suggested
11   II,     5.  2.  3|      ranges (all ages, 45-64, 45-74) have already been published (
12   II,     5.  2.  3|          et al, 2006).~In the 35-74 age-range, CVD accounts
13   II,     5.  2.  3|        mortality rates in the 35-74 age range fell by 38% in
14   II,     5.  2.  3|        ICD-9 410-14) Men aged 35-74 years~ ~Figure 5.2.2. Age-standardized
15   II,     5.  2.  3|      ICD-9 410-14) Women aged 35-74 years~ ~Morbidity~ ~Table
16   II,     5.  2.  3|        000 men and women aged 35-74 and 35-84 - 3 years average~ ~
17   II,     5.  3.  6|        breast cancer from 60% to 74%; prostate cancer from 40%
18   II,     5.  3.  7|         men and women aged 50 to 74 for the screening of colorectal
19   II,     5.  3.  9|           CA Cancer J Clin 55(2):74-108.~ ~Sant M, Aareleid
20   II,     5.  4.  4|       with a peak between 65 and 74 yrs, where all countries
21   II,     5.  4.  8|        Clinical Practice, Volume 74, Pages S215 – S219~Carstensen
22   II,     5.  4.  8|        Diab Res Clin Pract 2006; 74:S200-S204.~Morris AD, Boyle
23   II,     5.  5.  2|          30-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85-89, 90-
24   II,     5.  5.  3|          Eur J Neurol 12 Suppl 1:74-77.~Andrews G, Sandersson
25   II,     5.  5.  3|      Journal of Medical Genetics 74 (4):353-60.~Kahn RS, Fleischhacker
26   II,     5.  5.  3|          92), and 0.75 (95% CI 0.74-0.86), respectively.~Based
27   II,     5.  5.  3|        years of age children was 74-78% (Forsgren, 2004). In
28   II,     5.  5.  3|   Changing patterns of adult (4574 years) neurological deaths
29   II,     5.  5.  3|      Neurol Neurosurg Psychiatry 74:25-28.~Sundström P, Nyström
30   II,     5.  5.  3|      Neurol Neurosurg Psychiatry 74:29-32.~Sundström P, Svenningsson
31   II,     5.  5.  3|          Neuroepidemiology 22:65-74.~
32   II,     5.  6.  3|         men and women from 16 to 74 years of age in the UK General
33   II,     5.  6.  3|     example, in people aged 5574 the prevalence of OA of
34   II,     5.  6.  3|      prevalence in women aged 16-74.~ ~The incidence and prevalence
35   II,     5.  7.  3|        as a GFR <75 ml/min per 1.74 m2 ) of 12.1 cases per million
36   II,     5.  7.  3|          pmarp (<30 ml/min per 1.74 m2 ) (Esbjorner et al, 1997).
37   II,     5.  7.  3|        as a GFR <75 ml/min per 1.74 m2) of 74.7 cases pmarp (
38   II,     5.  7.  3|        75 ml/min per 1.74 m2) of 74.7 cases pmarp (Ardissino
39   II,     5.  7.  3|   defining CKD (<30 ml/min per 1.74 m2 ), the corresponding
40   II,     5.  7.  7|        Chinese adults aged 35 to 74 years. Kidney Int 2005;68(
41   II,     5.  9.  3|      correlation between asthma (74% of country level and 36%
42   II,     5.  9.  3|         20 showed increases, and 74 showed mixed changes. For
43   II,     5.  9.  4|          1 P <0.0002), asthma (1.74 to 1.02:1 P <0.0001), eczema (
44   II,     5. 11.  3|          24, 2534, 3554 and 5574, respectively (Rea et al,
45   II,     5. 11.  3|      common sites (84.2% BCC and 74.7% SCC) followed by the~
46   II,     5. 11.  7|     medical care among persons 174 years, United States, 1971–
47   II,     5. 14.  2|          15, 18 and 35-44 and 65-74 years in the four categories:
48   II,     5. 14.  2|          group 12, 15, 18 and 35-74 years in each of the four
49   II,     5. 14.  2|          group 12, 15, 18 and 35-74 years examined.~Only bleeding
50   II,     5. 14.  3|     factors. Only adults aged 65-74 present significant differences
51   II,     9.  4.  2|         only includes data up to 74 years of age. Although some
52   II,     9.  4.  3|       seen that up to the age of 74, men have the highest rate
53  III,    10.  2.  1|        extent for men, in the 45-74 years of age group. This
54  III,    10.  2.  1|     Sweden (82/77%), Denmark (83/74%) and Norway (86/75%). In
55  III,    10.  2.  1|         Oral Epidemiol 2004; 32: 74-76.~ ~ ~Petersen PE (2003):
56  III,    10.  4.  2|  amending Directives 70/524/EEC, 74/63/EEC, 79/373/EEC and 82/
57  III,    10.  5.  2|       Ireland for people aged 25-74 per area of residence~ ~
58  III,    10.  6.  1|         76% of 11 year old boys, 74% of 13 year old boys, and
59   IV,    11.  1.  5|      with the EU25 average being 74%. There are varying degrees
60   IV,    11.  6.  2|        the French population and 74% in Slovenia (though 98%
61   IV,    11.  6.  5|    Management Review 14 ,(4): 57-74.~ ~Epstein AM, Lee TH et
62   IV,    12.  2    |         men and women aged 50 to 74 for the screening of colorectal